Invitrogen™ Kit ELISA of rat EGFR

Ref.: BL-RE-092371Manufacturer ref.: ERA10RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

The epidermal growth factor receptor HER1, ErbB1 is encoded by the EGFR gene on chromosome 7 in humans. The EEGFR belongs to the HER/ERbB protein family, which includes three other tyrosine kinase receptors, ERbB2...

Accession number
P01590
Dose range
23 to 5 000 pg/ml
Sensitivity of the dosage
23 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

The epidermal growth factor receptor HER1, ErbB1 is encoded by the EGFR gene on chromosome 7 in humans. The EEGFR belongs to the HER/ERbB protein family, which includes three other tyrosine kinase receptors, ERbB2...

The epidermal growth factor receptor HER1, ErbB1 is encoded by the EGFR gene on chromosome 7 in humans. The EEGFR belongs to the HER/ERbB protein family, which includes three other tyrosine kinase receptors, ERbB2, ERbB3, ERbB4. The EGFR is a transmembrane receptor and the binding of its related ligands such as the EGF (epidermal growth factor) and the alpha transformation factor to the extracellular domain leads to the dimerization of the EGFR followed by the autophosphorylation of tyrosine residues in the cytoplasmic domain. The phosphorylation of the EGFR to certain residues is also induced by the Src-non-receptor kinase. The activation of the EGFR allows several downstream signal cascades such as the Ras - ERK, PI3-K - Akt, Jak - STAT and PKC pathways that contribute to cell growth and proliferation. The phosphorylation of the EGFR to Y1086 allows inter alia the binding of the GRB2 adaptor protein, leading to the activation of the MAPK pathway. During activation and signalling of receptors, the EGFR is endocytotic and targeted for degradation or recycling. Mutations in the EGFR gene are associated with lung cancer and several alternative-spinning transcription variants encoding different protein isoforms of the EGFR have been found. Increased production or activation of EGFR was associated with poor prognosis on a variety of tumours. In addition, the overexpression of EGFR is observed in tumours of the head and neck, brain, bladder, stomach, breast, lung, endometrium, cervix, vulva, ovary, esophagus, stomach, and epidermoid carcinoma.

Sensitivity

Sensitivity of dosage: 23 pg/ml.

Measurement range

Dose range: 23 to 5,000 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: EGFR.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17718203
Specifications
Accession numberP01590
Dose range23 to 5 000 pg/ml
Sensitivity of the dosage23 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)24329
Gene symbol(s)EGFR
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetEGFR
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl-Surnatant, 50 μl-Serum, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ERA10RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.